Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical value of identifying genes that inhibit hepatocellular carcinomas.

Expert review of molecular diagnostics - 1 Nov 2022

Testa Ugo, Pelosi Elvira, Castelli Germana

Abstract excerpt

INTRODUCTION: Primary liver cancer is a major health problem being the sixth most frequent cancer in the world and the fourth most frequent cause of cancer-related death in the world. The most common histological type of liver cancer is hepatocellular carcinoma (HCC, 75-80%). AREAS COVERED: Based on primary literature, this review provides an updated analysis of studies of genetic characterization of HCC at the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Carcinoma, Hepatocellular
Share to DNA Copy Number Variations

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Liver Neoplasms

Share to Mutation

Source

Identifiers

PMID: 36459631
DOI: 10.1080/14737159.2022.2154658

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical value of identifying genes that inhibit hepatocellular carcinomas.PMID 36459631Read ↗

Recent developments in molecular targeted therapies for hepatocellular carcinoma in the genomic era.Semantic proximity Read ↗

Overview of hepatocellular carcinoma: from molecular aspects to future therapeutic options.Semantic proximity Read ↗

Advances in molecular classification and precision oncology in hepatocellular carcinoma.Semantic proximity Read ↗

Molecular Targeted Therapy for Hepatocellular Carcinoma: Present Status and Future DirectionsSemantic proximity Read ↗

Molecular perspectives for the treatment of hepatocellular carcinoma.Semantic proximity Read ↗

Hepatocellular carcinoma: old friends and new tricksSemantic proximity Read ↗

The genetic and epigenetic alterations in human hepatocellular carcinoma: a recent update.Semantic proximity Read ↗

Integrating Genomics Into Clinical Practice in Hepatocellular Carcinoma: The Challenges AheadSemantic proximity Read ↗

Genetic alterations in hepatocellular carcinoma: An update.Semantic proximity Read ↗

Advances in Histological and Molecular Classification of Hepatocellular CarcinomaSemantic proximity Read ↗

The changing landscape of hepatocellular carcinoma: etiology, genetics, and therapy.Semantic proximity Read ↗

The perplexity of targeting genetic alterations in hepatocellular carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.